 |
 |
| |
Kollodis BioSciences is the first and leading company to commercialize recombinant mussel adhesive protein (MAP) and associated MAP-based smart biomaterials using its proprietary platform technology, MAPTrix™.
As a result of Kollodis' successful development of scaled-up processes for MAP manufacture, MAP-based smart biomaterials are currently poised for widespread use and growth in biotech, medical and industrial applications. |
|
|
 |